For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Jubilant Biosys Logo

Delivering the Added Dimension in Drug Discovery Services

4D White Icon

Delivering the Added Dimension in Drug Discovery

Time is a defining factor in drug discovery today. Our people, systems and processes are honed for delivering the highest quality results to enable our innovator customers to accelerate drug discovery for final IND submission.

4D White Icon

Deep & Defining Scientific Know-how

Employing dedicated scientists with over 14 years experience in oncology, metabolic disorders, CNS, pain, inflammation and fibrosis as well as multiple niche therapeutic areas.

4D White Icon

Delivering over 75 Integrated Discovery Projects

Our track record of achieving results is our platform for the future. Customers can choose individual functional services or a fully integrated solution.

4D White Icon

Diligent Quality through our Team Approach

A focus on quality and utilizing our highly qualified scientists is part of our ongoing process. The attention to detail needed at every stage from communication to implementation is built into our services.

4D White Icon

Developing your Drug Candidate

We rapidly scale-up your candidate for GLP TOX and GMP Phase 1 or 2 fully integrated with our PR&D and Analytical Teams. This saves valuable time to achieve your milestones.

Jubilant Biosys - Contract Research Organisation in India

Jubilant Biosys Ltd is a part of the Jubilant Life Sciences family of companies with R&D centers in India and business offices in Asia and North America. With our global reach, Jubilant Biosys provides comprehensive drug discovery services and contract research services - from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared) - in partnership with leading worldwide healthcare.

Latest News

Press Releases

Jubilant Life Sciences grants an exclusive license to Lengo Therapeutics to Discover and Develop Oncology Medicines

Upcoming Events

BIO KOREA 2020

Measures to curb the spread of novel Coronavirus (COVID-19)

Given the ongoing threat by the novel Coronavirus (COVID-19), Jubilant Life Sciences Limited has taken several measures to curb the spread of the contagious virus among its employees and stakeholders.  Click here to read the full statement

Our People

Find out more about the greatest strength of our business.

Our People

Future Expansion

Click to read more on the latest news on our DCC and Bengaluru facility.

Greater Noida Facility

Our 4D Approach

Click to get a snapshot of what our 4D thinking is.

Company Overview

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness of campaigns and analyse traffic. If you continue to use this site we will assume your acceptance.

;